NI, YONG,PARIKH, BHAVNISH,YELESWARAM, KRISHNASWAMY,ERICKSON-VIITANEN, SUSAN,WILLIAMS, WILLIAM V.
申请号：
PH12015501089
公开号：
PH12015501089A1
申请日:
2015.05.15
申请国别(地区):
PH
年份:
2015
代理人:
摘要：
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
